Skip to main content
TV Ad Spend Leaderboard

Who spends the most on TV drug ads?

Prescription medications ranked by their estimated annual television advertising budget — a look at the biggest spenders behind the ads you see every night.

Share

Maintained by TVPills Editorial Team · Information reviewed September 10, 2026

Combined Ad Spend

$13.2B

Advertisers Ranked

145

  1. 1

    Humira

    US

    adalimumab · Rheumatoid arthritis, psoriasis, Crohn's disease

    $500M

    est. / yr · catalogue record

  2. 2

    Skyrizi

    US

    risankizumab · Plaque psoriasis, psoriatic arthritis, Crohn's disease

    $480M

    est. / yr · catalogue record

  3. 3

    Ozempic

    US

    semaglutide · Type 2 diabetes

    $420M

    est. / yr · catalogue record

  4. 4

    Dupixent

    US

    dupilumab · Eczema, asthma, nasal polyps

    $390M

    est. / yr · catalogue record

  5. 5

    Wegovy

    US

    semaglutide · Chronic weight management, cardiovascular risk reduction

    $380M

    est. / yr · catalogue record

  6. 6

    Eliquis

    US

    apixaban · Blood clots, atrial fibrillation

    $350M

    est. / yr · catalogue record

  7. 7

    Mounjaro

    US

    tirzepatide · Type 2 diabetes

    $350M

    est. / yr · catalogue record

  8. 8

    Zepbound

    US

    tirzepatide · Chronic weight management, obstructive sleep apnea

    $300M

    est. / yr · catalogue record

  9. 9

    Jardiance

    US

    empagliflozin · Type 2 diabetes, heart failure, chronic kidney disease

    $280M

    est. / yr · catalogue record

  10. 10

    Keytruda

    US

    pembrolizumab · Multiple cancers

    $260M

    est. / yr · catalogue record

  11. 11

    Trulicity

    US

    dulaglutide · Type 2 diabetes

    $240M

    est. / yr · catalogue record

  12. 12

    Farxiga

    US

    dapagliflozin · Type 2 diabetes, heart failure, chronic kidney disease

    $220M

    est. / yr · catalogue record

  13. 13

    Xarelto

    US

    rivaroxaban · Blood clots, atrial fibrillation

    $210M

    est. / yr · catalogue record

  14. 14

    Vraylar

    US

    cariprazine · Bipolar disorder, schizophrenia, depression (add-on)

    $200M

    est. / yr · catalogue record

  15. 15

    Trelegy Ellipta

    US

    fluticasone/umeclidinium/vilanterol · COPD, asthma

    $200M

    est. / yr · catalogue record

  16. 16

    Taltz

    US

    ixekizumab · Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis

    $190M

    est. / yr · catalogue record

  17. 17

    Nurtec ODT

    US

    rimegepant · Migraine (acute and preventive)

    $190M

    est. / yr · catalogue record

  18. 18

    Rybelsus

    US

    semaglutide · Type 2 diabetes

    $180M

    est. / yr · catalogue record

  19. 19

    Biktarvy

    US

    bictegravir/emtricitabine/tenofovir alafenamide · HIV-1 infection

    $180M

    est. / yr · catalogue record

  20. 20

    Rinvoq

    US

    upadacitinib · Rheumatoid arthritis, psoriatic arthritis, eczema

    $175M

    est. / yr · catalogue record

  21. 21

    Rexulti

    US

    brexpiprazole · Major depression (add-on), schizophrenia, agitation in dementia

    $170M

    est. / yr · catalogue record

  22. 22

    Cosentyx

    US

    secukinumab · Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis

    $160M

    est. / yr · catalogue record

  23. 23

    Ubrelvy

    US

    ubrogepant · Acute migraine

    $160M

    est. / yr · catalogue record

  24. 24

    Entresto

    US

    sacubitril/valsartan · Chronic heart failure

    $150M

    est. / yr · catalogue record

  25. 25

    Opdivo

    US

    nivolumab · Multiple cancers

    $150M

    est. / yr · catalogue record

  26. 26

    Austedo

    US

    deutetrabenazine · Tardive dyskinesia, Huntington's chorea

    $150M

    est. / yr · catalogue record

  27. 27

    Xiidra

    US

    lifitegrast · Dry eye disease

    $150M

    est. / yr · catalogue record

  28. 28

    Shingrix

    US

    recombinant zoster vaccine · Shingles prevention

    $150M

    est. / yr · catalogue record

  29. 29

    Tremfya

    US

    guselkumab · Plaque psoriasis, psoriatic arthritis

    $140M

    est. / yr · catalogue record

  30. 30

    Linzess

    US

    linaclotide · Irritable bowel syndrome with constipation, chronic constipation

    $140M

    est. / yr · catalogue record

  31. 31

    Myrbetriq

    US

    mirabegron · Overactive bladder

    $140M

    est. / yr · catalogue record

  32. 32

    Stelara

    US

    ustekinumab · Psoriasis, Crohn's disease, ulcerative colitis

    $130M

    est. / yr · catalogue record

  33. 33

    Caplyta

    US

    lumateperone · Schizophrenia, bipolar depression

    $130M

    est. / yr · catalogue record

  34. 34

    Trintellix

    US

    vortioxetine · Major depressive disorder

    $130M

    est. / yr · catalogue record

  35. 35

    Xifaxan

    US

    rifaximin · Irritable bowel syndrome with diarrhea, hepatic encephalopathy

    $130M

    est. / yr · catalogue record

  36. 36

    Sotyktu

    US

    deucravacitinib · Plaque psoriasis

    $130M

    est. / yr · catalogue record

  37. 37

    Repatha

    US

    evolocumab · High cholesterol, cardiovascular disease

    $120M

    est. / yr · catalogue record

  38. 38

    Qulipta

    US

    atogepant · Migraine prevention

    $120M

    est. / yr · catalogue record

  39. 39

    Breztri Aerosphere

    US

    budesonide/glycopyrrolate/formoterol · COPD

    $120M

    est. / yr · catalogue record

  40. 40

    Brilinta

    US

    ticagrelor · Acute coronary syndrome, heart attack prevention

    $120M

    est. / yr · catalogue record

  41. 41

    Prolia

    US

    denosumab · Osteoporosis

    $120M

    est. / yr · catalogue record

  42. 42

    Symbicort

    US

    budesonide/formoterol · Asthma, COPD

    $120M

    est. / yr · catalogue record

  43. 43

    Otezla

    US

    apremilast · Plaque psoriasis, psoriatic arthritis, Behçet's disease

    $110M

    est. / yr · catalogue record

  44. 44

    Veozah

    US

    fezolinetant · Menopausal hot flashes

    $110M

    est. / yr · catalogue record

  45. 45

    Invokana

    US

    canagliflozin · Type 2 diabetes, diabetic kidney disease

    $110M

    est. / yr · catalogue record

  46. 46

    Emgality

    US

    galcanezumab · Migraine prevention, cluster headache

    $110M

    est. / yr · catalogue record

  47. 47

    Arexvy

    US

    respiratory syncytial virus vaccine · RSV prevention in older adults

    $110M

    est. / yr · catalogue record

  48. 48

    Restasis

    US

    cyclosporine ophthalmic emulsion · Chronic dry eye

    $100M

    est. / yr · catalogue record

  49. 49

    Aimovig

    US

    erenumab · Migraine prevention

    $100M

    est. / yr · catalogue record

  50. 50

    Breo Ellipta

    US

    fluticasone/vilanterol · Asthma, COPD

    $100M

    est. / yr · catalogue record

  51. 51

    Cialis

    US

    tadalafil · Erectile dysfunction, enlarged prostate (BPH)

    $100M

    est. / yr · catalogue record

  52. 52

    Humira

    CA

    adalimumab · Rheumatoid arthritis, psoriasis, Crohn's disease

    $95M

    est. / yr · catalogue record

  53. 53

    Entyvio

    US

    vedolizumab · Ulcerative colitis, Crohn's disease

    $95M

    est. / yr · catalogue record

  54. 54

    Xolair

    US

    omalizumab · Allergic asthma, chronic hives, food allergy

    $95M

    est. / yr · catalogue record

  55. 55

    Dovato

    US

    dolutegravir/lamivudine · HIV-1 infection

    $95M

    est. / yr · catalogue record

  56. 56

    Leqvio

    US

    inclisiran · High cholesterol, cardiovascular disease

    $90M

    est. / yr · catalogue record

  57. 57

    Vascepa

    US

    icosapent ethyl · High triglycerides, cardiovascular risk reduction

    $90M

    est. / yr · catalogue record

  58. 58

    Eylea

    US

    aflibercept · Wet macular degeneration, diabetic eye disease

    $90M

    est. / yr · catalogue record

  59. 59

    Xeljanz

    US

    tofacitinib · Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis

    $90M

    est. / yr · catalogue record

  60. 60

    Chantix

    US

    varenicline · Smoking cessation

    $90M

    est. / yr · catalogue record

  61. 61

    Xtandi

    US

    enzalutamide · Prostate cancer

    $90M

    est. / yr · catalogue record

  62. 62

    Ozempic

    CA

    semaglutide · Type 2 diabetes

    $85M

    est. / yr · catalogue record

  63. 63

    Verzenio

    US

    abemaciclib · HR+/HER2- breast cancer

    $85M

    est. / yr · catalogue record

  64. 64

    Vabysmo

    US

    faricimab · Wet macular degeneration, diabetic macular edema

    $85M

    est. / yr · catalogue record

  65. 65

    Latuda

    US

    lurasidone · Schizophrenia, bipolar depression

    $85M

    est. / yr · catalogue record

  66. 66

    Ibrance

    US

    palbociclib · HR+/HER2- breast cancer

    $80M

    est. / yr · catalogue record

  67. 67

    Gemtesa

    US

    vibegron · Overactive bladder

    $80M

    est. / yr · catalogue record

  68. 68

    Fasenra

    US

    benralizumab · Severe eosinophilic asthma

    $80M

    est. / yr · catalogue record

  69. 69

    Mavyret

    US

    glecaprevir/pibrentasvir · Hepatitis C

    $80M

    est. / yr · catalogue record

  70. 70

    Kisqali

    US

    ribociclib · HR-positive, HER2-negative breast cancer

    $80M

    est. / yr · catalogue record

  71. 71

    Eliquis

    CA

    apixaban · Blood clots, atrial fibrillation

    $75M

    est. / yr · catalogue record

  72. 72

    Cibinqo

    US

    abrocitinib · Atopic dermatitis (eczema)

    $75M

    est. / yr · catalogue record

  73. 73

    Nucala

    US

    mepolizumab · Severe eosinophilic asthma, COPD, nasal polyps

    $75M

    est. / yr · catalogue record

  74. 74

    Quviviq

    US

    daridorexant · Insomnia

    $75M

    est. / yr · catalogue record

  75. 75

    Vuity

    US

    pilocarpine ophthalmic · Age-related blurry near vision (presbyopia)

    $70M

    est. / yr · catalogue record

  76. 76

    Evenity

    US

    romosozumab · Osteoporosis (high fracture risk)

    $70M

    est. / yr · catalogue record

  77. 77

    Ajovy

    US

    fremanezumab · Migraine prevention

    $70M

    est. / yr · catalogue record

  78. 78

    Tezspire

    US

    tezepelumab · Severe asthma

    $70M

    est. / yr · catalogue record

  79. 79

    Vyvanse

    US

    lisdexamfetamine · ADHD, binge eating disorder

    $70M

    est. / yr · catalogue record

  80. 80

    Dupixent

    CA

    dupilumab · Eczema, asthma, nasal polyps

    $65M

    est. / yr · catalogue record

  81. 81

    Litfulo

    US

    ritlecitinib · Severe alopecia areata

    $65M

    est. / yr · catalogue record

  82. 82

    Icotyde

    US

    icotrokinra · Plaque psoriasis

    $65M

    est. / yr · catalogue record

  83. 83

    Lipitor

    US

    atorvastatin · High cholesterol, cardiovascular prevention

    $60M

    est. / yr · catalogue record

  84. 84

    Kerendia

    US

    finerenone · Chronic kidney disease in type 2 diabetes

    $60M

    est. / yr · catalogue record

  85. 85

    Olumiant

    US

    baricitinib · Rheumatoid arthritis, severe alopecia areata

    $60M

    est. / yr · catalogue record

  86. 86

    Paxlovid

    US

    nirmatrelvir/ritonavir · COVID-19 (mild to moderate)

    $60M

    est. / yr · catalogue record

  87. 87

    Orilissa

    US

    elagolix · Endometriosis pain

    $60M

    est. / yr · catalogue record

  88. 88

    Jardiance

    CA

    empagliflozin · Type 2 diabetes, heart failure, chronic kidney disease

    $55M

    est. / yr · catalogue record

  89. 89

    Bimzelx

    US

    bimekizumab · Plaque psoriasis, psoriatic arthritis

    $55M

    est. / yr · catalogue record

  90. 90

    Auvelity

    US

    dextromethorphan/bupropion · Major depressive disorder

    $50M

    est. / yr · catalogue record

  91. 91

    Skyrizi

    CA

    risankizumab · Plaque psoriasis, psoriatic arthritis, Crohn's disease

    $48M

    est. / yr · catalogue record

  92. 92

    Crestor

    US

    rosuvastatin · High cholesterol, cardiovascular prevention

    $45M

    est. / yr · catalogue record

  93. 93

    Keytruda

    CA

    pembrolizumab · Multiple cancers

    $42M

    est. / yr · catalogue record

  94. 94

    Mounjaro

    CA

    tirzepatide · Type 2 diabetes

    $40M

    est. / yr · catalogue record

  95. 95

    Rinvoq

    CA

    upadacitinib · Rheumatoid arthritis, psoriatic arthritis, eczema

    $38M

    est. / yr · catalogue record

  96. 96

    Repatha

    CA

    evolocumab · High cholesterol, cardiovascular disease

    $32M

    est. / yr · catalogue record

  97. 97

    Victoza

    CA

    liraglutide · Type 2 diabetes, obesity

    $28M

    est. / yr · catalogue record

  98. 98

    Xarelto

    CA

    rivaroxaban · Blood clots, atrial fibrillation

    $28M

    est. / yr · catalogue record

  99. 99

    Trulicity

    CA

    dulaglutide · Type 2 diabetes

    $26M

    est. / yr · catalogue record

  100. 100

    Tylenol

    CA

    acetaminophen · Pain relief, fever

    $14M

    est. / yr · catalogue record

  101. 101

    Advair

    CA

    fluticasone/salmeterol · Asthma, COPD

    $12M

    est. / yr · catalogue record

  102. 102

    Voltaren

    NZ

    diclofenac · Arthritis, muscle pain, joint pain

    $12M

    est. / yr · catalogue record

  103. 103

    Symbicort

    CA

    budesonide/formoterol · Asthma, COPD

    $11M

    est. / yr · catalogue record

  104. 104

    Nurofen

    NZ

    ibuprofen · Pain relief, inflammation, fever

    $10M

    est. / yr · catalogue record

  105. 105

    Nexium

    CA

    esomeprazole · Acid reflux, GERD, ulcers

    $9M

    est. / yr · catalogue record

  106. 106

    Lipitor

    CA

    atorvastatin · High cholesterol, cardiovascular prevention

    $8M

    est. / yr · catalogue record

  107. 107

    Nasonex

    NZ

    mometasone · Allergic rhinitis, hay fever, nasal polyps

    $8M

    est. / yr · catalogue record

  108. 108

    Nicorette

    NZ

    nicotine · Smoking cessation

    $8M

    est. / yr · catalogue record

  109. 109

    Crestor

    CA

    rosuvastatin · High cholesterol, cardiovascular prevention

    $7M

    est. / yr · catalogue record

  110. 110

    Ventolin

    CA

    salbutamol · Asthma, bronchospasm

    $6M

    est. / yr · catalogue record

  111. 111

    Nexium

    NZ

    esomeprazole · Acid reflux, GERD, stomach ulcers

    $6M

    est. / yr · catalogue record

  112. 112

    Claratyne

    NZ

    loratadine · Hay fever, allergic rhinitis, hives

    $6M

    est. / yr · catalogue record

  113. 113

    Synthroid

    CA

    levothyroxine · Hypothyroidism

    $5M

    est. / yr · catalogue record

  114. 114

    Panadol

    NZ

    paracetamol · Pain relief, fever

    $5M

    est. / yr · catalogue record

  115. 115

    Fosamax

    NZ

    alendronate · Osteoporosis

    $5M

    est. / yr · catalogue record

  116. 116

    Cipralex

    CA

    escitalopram · Depression, anxiety

    $4M

    est. / yr · catalogue record

  117. 117

    Telfast

    NZ

    fexofenadine · Hay fever, allergic rhinitis, hives

    $4M

    est. / yr · catalogue record

  118. 118

    Champix

    NZ

    varenicline · Smoking cessation

    $4M

    est. / yr · catalogue record

  119. 119

    Zyrtec

    NZ

    cetirizine · Hay fever, allergies, hives

    $4M

    est. / yr · catalogue record

  120. 120

    Lipitor

    NZ

    atorvastatin · High cholesterol, cardiovascular disease prevention

    $4M

    est. / yr · catalogue record

  121. 121

    Concerta

    CA

    methylphenidate · ADHD

    $3M

    est. / yr · catalogue record

  122. 122

    Losec

    NZ

    omeprazole · Acid reflux, stomach ulcers, GERD

    $3M

    est. / yr · catalogue record

  123. 123

    Ozempic

    NZ

    semaglutide · Type 2 diabetes

    $3M

    est. / yr · catalogue record

  124. 124

    Otrivin

    NZ

    xylometazoline · Nasal congestion, cold and sinus relief

    $3M

    est. / yr · catalogue record

  125. 125

    Ventolin

    NZ

    salbutamol · Asthma, bronchospasm

    $3M

    est. / yr · catalogue record

  126. 126

    Symbicort

    NZ

    budesonide/formoterol · Asthma, COPD

    $3M

    est. / yr · catalogue record

  127. 127

    Altace

    CA

    ramipril · High blood pressure, heart protection

    $2M

    est. / yr · catalogue record

  128. 128

    Glucophage

    CA

    metformin · Type 2 diabetes

    $2M

    est. / yr · catalogue record

  129. 129

    Pantoloc

    CA

    pantoprazole · Acid reflux, GERD, ulcers

    $2M

    est. / yr · catalogue record

  130. 130

    Seretide

    NZ

    fluticasone/salmeterol · Asthma, COPD

    $2M

    est. / yr · catalogue record

  131. 131

    Jardiance

    NZ

    empagliflozin · Type 2 diabetes, heart failure

    $2M

    est. / yr · catalogue record

  132. 132

    Metformin

    US

    metformin · Type 2 diabetes

    $2M

    est. / yr · catalogue record

  133. 133

    Cymbalta

    NZ

    duloxetine · Depression, anxiety, nerve pain

    $2M

    est. / yr · catalogue record

  134. 134

    Glucophage

    NZ

    metformin · Type 2 diabetes

    $1M

    est. / yr · catalogue record

  135. 135

    Augmentin

    NZ

    amoxicillin/clavulanate · Bacterial infections

    $1M

    est. / yr · catalogue record

  136. 136

    Loxalate

    NZ

    escitalopram · Depression, anxiety

    $1M

    est. / yr · catalogue record

  137. 137

    Mobic

    NZ

    meloxicam · Arthritis, joint inflammation

    $1M

    est. / yr · catalogue record

  138. 138

    Somac

    NZ

    pantoprazole · Acid reflux, GERD, ulcers

    $1M

    est. / yr · catalogue record

  139. 139

    Lisinopril

    US

    lisinopril · High blood pressure, heart failure

    $1M

    est. / yr · catalogue record

  140. 140

    Amoxicillin

    US

    amoxicillin · Bacterial infections

    $1M

    est. / yr · catalogue record

  141. 141

    Gabapentin

    US

    gabapentin · Nerve pain, seizures

    $1M

    est. / yr · catalogue record

  142. 142

    Adderall

    US

    amphetamine/dextroamphetamine · ADHD, narcolepsy

    $1M

    est. / yr · catalogue record

  143. 143

    Synthroid

    US

    levothyroxine · Hypothyroidism

    $1M

    est. / yr · catalogue record

  144. 144

    Prednisone

    US

    prednisone · Inflammation, autoimmune flares, allergic reactions

    $1M

    est. / yr · catalogue record

  145. 145

    Zoloft

    US

    sertraline · Depression, anxiety, OCD, PTSD

    $1M

    est. / yr · catalogue record

TV drug ad spend: frequently asked questions

Which prescription drug spends the most on TV advertising?

Humira has the largest estimated TV ad budget at about $500M a year, making it the biggest TV advertiser among the drugs we track.

How much do prescription drugs spend on TV ads in total?

The 145 TV-advertised drugs on this leaderboard have a combined estimated annual TV ad budget of about $13.2B across the US, Canada, and New Zealand.

Why do drug companies advertise so much on TV?

Prescription drugs are among the most heavily advertised products on American television because direct-to-consumer ads encourage patients to ask their doctors about brand-name medicines — which can drive significant sales for high-priced drugs.

Which countries allow prescription drug ads on TV?

Only the United States and New Zealand allow full direct-to-consumer prescription drug advertising, so nearly all TV drug ad spending happens in those two countries.

Sources & methodology

Source dataset: TVPills maintained drug catalogue (TVPills Editorial Team). The catalogue snapshot used for these figures was retrieved September 10, 2026.

Calculation: Each drug record's tvAdBudgetMillions value is treated as an estimated annual budget in millions of US dollars. Rankings sort records descending by that value; totals and group totals sum each positive record once, without weighting or extrapolating from commercial counts. Each individual amount in the rankings links to the corresponding catalogue record; grouped totals use the same record-level values.

Limitations: These values are editorial estimates, not company-reported or independently audited media-buying figures. The catalogue does not currently attach a public third-party publication to each estimate, so the figures should not be used as financial, investment, or market-size data.

Source status: Internal editorial estimate. No company filing or independent media-buying dataset is being presented as the source for these values.

Embed this leaderboard

Run a health, news, or finance site? Drop this leaderboard into any page — it stays up to date automatically. Please keep the credit link.

TVPills

A reference tool to help identify prescription medications and supplements seen in television advertising. This is not medical advice. Always consult a healthcare professional.

TVPills is independent and not affiliated with, endorsed by, or sponsored by any drug manufacturer or brand. All trademarks are the property of their respective owners. Some links are affiliate links; we may earn a commission at no extra cost to you.